Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 80 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Outer membrane vesicle-based intranasal vaccines.
Van der Ley P, Schijns VE
Curr Opin Immunol, 84:102376, 18 Aug 2023
Cited by: 2 articles | PMID: 37598549
Add to export list Review
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Bota DA, Taylor TH, Lomeli N, Kong XT, Fu BD, Schönthal AH, Singer S, Blumenthal DT, Senecal FM, Linardou H, Rokas E, Antoniou DG, Schijns VEJC, Chen TC, Elliot J, Stathopoulos A
Front Oncol, 12:934638, 28 Jun 2022
Cited by: 2 articles | PMID: 35837107 | PMCID: PMC9273968
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation.
Schijns V, Majhen D, van der Ley P, Thakur A, Summerfield A, Berisio R, Nativi C, Fernández-Tejada A, Alvarez-Dominguez C, Gizurarson S, Zamyatina A, Molinaro A, Rosano C, Jakopin Ž, Gursel I, McClean S
Pharmaceutics, 13(4):501, 06 Apr 2021
Cited by: 13 articles | PMID: 33917629 | PMCID: PMC8067490
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CTIM-09. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: VACCINE OVERALL SURVIVAL IN BEVACIZUMAB NAIVE AND BEVACIZUMAB RESISTANT PATIENTS
Bota D, Taylor T, Kong X, Fu B, Hsu F, Strik A, Schijns V, Stathopoulos A
Neuro Oncol, 22(suppl 2):ii34-ii34, 01 Nov 2020
Cited by: 0 articles | PMCID: PMC7650378
Add to export list Free full text in Europe PMC
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination.
Schijns V, Fernández-Tejada A, Barjaktarović Ž, Bouzalas I, Brimnes J, Chernysh S, Gizurarson S, Gursel I, Jakopin Ž, Lawrenz M, Nativi C, Paul S, Pedersen GK, Rosano C, Ruiz-de-Angulo A, Slütter B, Thakur A, Christensen D, Lavelle EC
Immunol Rev, 296(1):169-190, 28 Jun 2020
Cited by: 32 articles | PMID: 32594569 | PMCID: PMC7497245
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V, Lavelle EC
Eur J Immunol, 50(7):932-938, 15 Jun 2020
Cited by: 42 articles | PMID: 32438473 | PMCID: PMC7280664
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
ATIM-42. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: OS CORRELATIONS WITH INITIAL AND MAXIMUM CD4+T LYMPHOCYTE COUNT IN THE PERIPHERAL BLOOD
Bota D, Taylor T, Xiao-Tang K, Fu B, Alsharif M, Pretto C, Strik A, Schijns V, Stathopoulos A
Neuro Oncol, 21(suppl 6):vi10-vi11, 01 Nov 2019
Cited by: 0 articles | PMCID: PMC6847420
Add to export list Free full text in Europe PMC
ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS
Bota D, Chung J, Dandekar M, Carrillo J, Kong X, Beverly Fu D, Hsu F, Schönthal A, Hofman F, Chen T, Zidovetzki R, Pretto C, Strik A, Schijns V, Stathopoulos A
Neuro Oncol, 20(suppl 6):vi7-vi7, 01 Nov 2018
Cited by: 0 articles | PMCID: PMC6216140
Add to export list Free full text in Europe PMC
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4⁺ T-lymphocyte counts.
Bota DA, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FP, Schönthal AH, Hofman FM, Chen TC, Zidovetzki R, Pretto C, Strik A, Schijns VE, Stathopoulos A
CNS Oncol, 7(3):CNS22, 01 Jul 2018
Cited by: 43 articles | PMID: 30157683 | PMCID: PMC6200061
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Therapeutic Immunization against Glioblastoma.
Schijns VEJC, Pretto C, Strik AM, Gloudemans-Rijkers R, Deviller L, Pierre D, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FPK, Hofman FM, Chen TC, Zidovetzki R, Bota DA, Stathopoulos A
Int J Mol Sci, 19(9):E2540, 27 Aug 2018
Cited by: 9 articles | PMID: 30150597 | PMCID: PMC6163986
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
Dobrovolskienė N, Pašukonienė V, Darinskas A, Kraśko JA, Žilionytė K, Mlynska A, Gudlevičienė Ž, Mišeikytė-Kaubrienė E, Schijns V, Lubitz W, Kudela P, Strioga M
Vaccine, 36(29):4171-4180, 09 Jun 2018
Cited by: 16 articles | PMID: 29895501
Add to export list
HOUT-17. A PRELIMINARY DATA REPORT ON A PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA
Bota D, Chung J, Carrillo J, Kong X, Fu B, Pretto C, Strik A, Schijns V, Stathopoulos A
Neuro Oncol, 19(suppl 6):vi109-vi109, 01 Nov 2017
Cited by: 0 articles | PMCID: PMC5692303
Add to export list Free full text in Europe PMC
Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines.
Savelkoul HF, Ferro VA, Strioga MM, Schijns VE
Vaccines (Basel), 3(1):148-171, 05 Mar 2015
Cited by: 40 articles | PMID: 26344951 | PMCID: PMC4494243
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.
Bota DA, Alexandru-Abrams D, Pretto C, Hofman FM, Chen TC, Fu B, Carrillo JA, Schijns VE, Stathopoulos A
Perm J, 19(2):41-46, 01 Mar 2015
Cited by: 10 articles | PMID: 25785641 | PMCID: PMC4403580
Add to export list Free full text in Europe PMC
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.
Schijns VE, Pretto C, Devillers L, Pierre D, Hofman FM, Chen TC, Mespouille P, Hantos P, Glorieux P, Bota DA, Stathopoulos A
Vaccine, 33(23):2690-2696, 10 Apr 2015
Cited by: 32 articles | PMID: 25865468 | PMCID: PMC10494870
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Oil-based emulsion vaccine adjuvants.
Schijns VEJC, Strioga M, Ascarateil S
Curr Protoc Immunol, 106:2.18.1-2.18.7, 01 Aug 2014
Cited by: 2 articles | PMID: 25081910
Add to export list Review
ET-54IMMUNOTHERAPY BASED ON TUMOR TRANSPLANT ANTIGEN RECOGNITION EMERGES AS A PROMISING STRATEGY FOR RECURRENT GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
Schijns V, Pretto C, Devillers L, Pierre D, Hofman F, Kruse C, Chen T, Oertel J, Hantos P, Bota D, Stathopoulos A
Neuro Oncol, 16(suppl 5):v90-v91, 01 Nov 2014
Cited by: 0 articles | PMCID: PMC4218150
Add to export list Free full text in Europe PMC
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?
Strioga MM, Darinskas A, Pasukoniene V, Mlynska A, Ostapenko V, Schijns V
Vaccine, 32(32):4015-4024, 14 May 2014
Cited by: 19 articles | PMID: 24837511
Add to export list Review
Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Schijns V, Tartour E, Michalek J, Stathopoulos A, Dobrovolskienė NT, Strioga MM
Cytotherapy, 16(4):427-439, 23 Nov 2013
Cited by: 15 articles | PMID: 24280238
Add to export list Review
Therapeutic dendritic cell-based cancer vaccines: the state of the art.
Strioga MM, Felzmann T, Powell DJ, Ostapenko V, Dobrovolskiene NT, Matuskova M, Michalek J, Schijns VE
Crit Rev Immunol, 33(6):489-547, 01 Jan 2013
Cited by: 26 articles | PMID: 24266347
Add to export list Review
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation.
Stathopoulos A, Pretto C, Devillers L, Pierre D, Hofman FM, Kruse C, Jadus M, Chen TC, Schijns VE
Oncoimmunology, 1(3):298-305, 01 May 2012
Cited by: 16 articles | PMID: 22737605 | PMCID: PMC3382858
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.
Pérez O, Batista-Duharte A, González E, Zayas C, Balboa J, Cuello M, Cabrera O, Lastre M, Schijns VE
Braz J Med Biol Res, 45(8):681-692, 26 Apr 2012
Cited by: 26 articles | PMID: 22527130 | PMCID: PMC3854239
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dendritic cells and their role in tumor immunosurveillance.
Strioga M, Schijns V, Powell DJ, Pasukoniene V, Dobrovolskiene N, Michalek J
Innate Immun, 19(1):98-111, 25 Jun 2012
Cited by: 32 articles | PMID: 22732734
Add to export list Review
CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES
Pollack I, Jakacki R, Butterfield L, Okada H, Valle R, Tejada S, Inogés S, Idoate M, de Cerio A, Espinos J, Aristu J, Gallego J, Calvo J, Bendandi M, Chen C, Ravelo A, Yu E, Dhanda R, Schnadig I, [...] Khachatryan W
Neuro Oncol, 14(suppl 6):vi43-vi49, 01 Oct 2012
Cited by: 0 articles | PMCID: PMC3488778
Add to export list Free full text in Europe PMC
Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators.
Stathopoulos A, Pretto C, Devillers L, Pierre D, Hofman FM, Epstein AL, Farghadani H, Kruse CA, Jadus MR, Chen TC, Schijns VE
J Clin Cell Immunol, Suppl 5:004, 01 Jan 2012
Cited by: 3 articles | PMID: 24955288 | PMCID: PMC4062195
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 80 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding